About Percutaneous Coronary Intervention (PCI) Devices
Percutaneous coronary intervention (PCI) is a non-surgical procedure, in which a catheter is used to place stent to broaden the narrowed coronary arteries. PCI is widely used to treat obstructive coronary heart diseases such as multi-vessel coronary disease (CAD) unstable angina and acute myocardial infraction(AMI) effectively. Many factors contribute to the high incidence of CAD, for instance sedentary lifestyle, diabetes, high blood pressure, and excessive alcohol and tobacco consumption.
Technavio’s analysts forecast the global percutaneous coronary intervention (PCI) devices market to grow at a CAGR of 5.73% during the period 2017-2021.
Covered in this report
The report covers the present scenario and the growth prospects of the global percutaneous coronary intervention (PCI) devices market for 2017-2021. The report presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources.
The market is divided into the following segments based on geography:
• Americas
• APAC
• EMEA
Technavio's report, Global Percutaneous Coronary Intervention (PCI) Devices Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors
• Boston Scientific
• Abbott
• Medtronic
• Cordis
• Terumo Medical
Other prominent vendors
• AMG International
• ASAHI INTECC
• B. Braun Melsungen
• BioSensors
• BIOTRONIK
• BrosMed Medical
• Claret Medical
• Comed BV
• Contego Medical
• Elixir Medical
• EPflex Feinwerktechnik
• GaltNeedleTech
• Lepu Medical
• Meril Life Sciences
• Merit Medical Systems
• optimed Medizinische Instrumente
• ORBUSNEICH
• Penumbra
• RONTIS
• SP Medical
• STENTYS
• Teleflex
Market driver
• High incidence of CAD
• For a full, detailed list, view our report
Market challenge
• Stringent government regulations
• For a full, detailed list, view our report
Market trend
• Technological advances
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2021 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.
Table of Contents
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
• Market outline
PART 05: MARKET LANDSCAPE
• Market overview
• Five forces analysis
PART 06: MARKET SEGMENTATION BY PRODUCT
• Coronary stents
• PTCA catheters
• Coronary guidewires
• Embolic Protection Devices (EPDs)
PART 07: MARKET SEGMENTATION BY END-USER
• Hospitals
• ASCs
• Cath labs
PART 08: REGIONAL LANDSCAPE
• Regional comparison
• Americas – market size & forecast
• EMEA – market size & forecast
• APAC – market size & forecast
• Market opportunity
PART 09: DECISION FRAMEWORK
PART 10: DRIVERS AND CHALLENGES
• Market drivers
• Market challenges
PART 11: MARKET TRENDS
• Technological advances
• Vendors' changing focus toward bioresorbable stents
• Use of robotic PCI systems
PART 12: VENDOR LANDSCAPE
• Competitive scenario
• Key news
• M&A
PART 13: KEY VENDOR ANALYSIS
• Boston Scientific
• Abbott
• Medtronic
• Cordis
• Terumo Medical
• Other prominent vendors
PART 14: APPENDIX
• List of abbreviations
List of Exhibits
Exhibit 01: Global PCI devices market 2016-2021 ($ millions)
Exhibit 02: Five forces analysis
Exhibit 03: Global PCI devices market by product 2016 ($ millions)
Exhibit 04: Global PCI devices market by product 2016-2021 ($ millions)
Exhibit 05: Global PCI devices market by product 2016-2021 (%)
Exhibit 06: Global PCI devices market by product 2016 and 2021 (%)
Exhibit 07: Global PCI devices market by product 2016 and 2021 ($ millions)
Exhibit 08: Global PCI devices market by product market share 2016
Exhibit 09: Global PCI devices market segmentation
Exhibit 10: The global coronary stents market 2016-2021 ($ millions)
Exhibit 11: Global PTCA catheters market 2016-2021 ($ millions)
Exhibit 12: Global coronary guidewires market 2016-2021 ($ millions)
Exhibit 13: Global EPDs market 2016-2021 ($ millions)
Exhibit 14: Global PCI devices market by end-users 2016
Exhibit 15: Global PCI devices market analysis 2016
Exhibit 16: The global PCI devices market 2016 and 2021 ($ Million)
Exhibit 17: The global PCI devices market 2016 and 2021 (%)
Americas – market size & forecast
Exhibit 18: Regional comparison
Exhibit 19: Americas – market size & forecast
Exhibit 20: Americas – Year over year growth
Exhibit 21: Top 3 countries in Americas
Exhibit 22: EMEA – market size & forecast
Exhibit 23: EMEA – Year over year growth
Exhibit 24: Top 3 countries in EMEA
Exhibit 25: APAC – market size & forecast
Exhibit 26: APAC – Year over year growth
Exhibit 27: Top 3 countries in APAC
Exhibit 28: Product launches in global PCI devices market
Exhibit 29: Product recalls in PCI devices market
Exhibit 30: Few advanced embolic protection devices
Exhibit 31: Competitive structure analysis of global PCI devices market 2016
Exhibit 32: Percentage share of vendors in global PCI devices market 2016
Exhibit 33: Boston Scientific: Key highlights
Exhibit 34: Boston Scientific: Strength assessment
Exhibit 35: Boston Scientific: Strategy assessment
Exhibit 36: Boston Scientific: Opportunity assessment
Exhibit 37: Abbott: Key highlights
Exhibit 38: Abbott: Strength assessment
Exhibit 39: Abbott: Strategy assessment
Exhibit 40: Abbott: Opportunity assessment
Exhibit 41: Medtronic: Key highlights
Exhibit 42: Medtronic: Strength assessment
Exhibit 43: Medtronic: Strategy assessment
Exhibit 44: Medtronic: Opportunity assessment
Exhibit 45: Cordis: Key highlights
Exhibit 46: Cordis: Strength assessment
Exhibit 47: Cordis: Strategy assessment
Exhibit 48: Cordis: Opportunity assessment
Exhibit 49: Terumo Medical: key highlights
Exhibit 50: Terumo Medical: Strength assessment
Exhibit 51: Terumo Medical: Strategy assessment
Exhibit 52: Terumo Medical: Opportunity assessment
